Blog
Webinar, Mark2Curathon, and more
Learn how you can contribute to biomedical citizen science in a webinar by Mark2Cure and Cochrane Crowd. Then join our citizen science screening events!
New Data Release for MyVariant.info 201704
With the latest updates in ClinVar, dbSNP, dbNSFP, MyVariant.info now serves over 425 million genetic variant annotations from over 14 data sources.
Pathway data updated in MyGene.info
Just a quick highlight of our recent update on all pathway data in MyGene.info API. Thanks to the excellent pathway/interaction database from ConsensusPathDB, we updated all 10 pathway sub-fields (listed below) for three species (human, mouse and yeast). The underlying data were updated up to Jan 2017 (ConsensusPathDB
Celebrating the application of citizen science towards biomedical literature
Mark2Cure approaches the biomedical literature problem with citizen science, and we are not alone! Join us and Cochrane Crowd for out anniversary
The Disease Ontology license converted to CC0
[Editor note: This guest blog post is from Lynn Schriml, who is an Associate Professor at the University of Maryland School of Medicine, the PI of the Disease Ontology, and a close collaborator on the Gene Wiki project.] Licensing of bioinformatics resources through...
New Entity Recognition Mission Available
Pilocarpine is a drug that was identified by volunteers in previous missions (literature sets), help find clues for NGLY1 deficiency in this new mission.
New Data Release 201703
With recent updates from ClinVar, dbSNP, & dbNSFP, MyVariant now serves over 341 million variant annotations from over 14 major gene variant databases.
Happy St. Patty’s day!
We have a new citizen science project in development for annotating clinical and drug indications. Learn how you can help especially if you Mark2Cure!
Upcoming Mark2Cure-related events
San Diego Citizen Science Expo 2017 will be held on March 11 at the La Jolla Library. Join Mark2Cure, American Gut, PinBoat, Science Game Lab, and more!
Mark2Cure Beta Study officially published
Mark2Cure’s first academic paper is finally published. For those of you who have been with us for a while, you may recall the posting of our preprint to biorxiv last January, so why was it only ‘published’ recently? Since all of our contributors are helping to make sense of